Seres Therapeutics, Inc. Payments to Acquire Short-term Investments
Seres Therapeutics, Inc. (MCRB) reported Payments to Acquire Short-term Investments of $267.76 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2016-03-14
- Seres Therapeutics, Inc. payments to acquire short-term investments for fiscal 2015 was $267.76M.
| Period end | Payments to Acquire Short-term Investments 12 month |
|---|---|
| 2015-12-31 | $267.76M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |